News

Recaticimab cuts LDL-C by over 60% with 12-week dosing, offering a promising lipid-lowering option for nonfamilial hypercholesterolemia patients on stable statin therapy.

Machine learning predicts occurrence and mortality of sepsis-associated ARDS with high accuracy, study reveals.

Diagnostic superiority of [68Ga]Ga-NYM046 PET/CT over the conventional [18F]FDG PET/CT in detecting clear cell renal cell carcinoma

A study has developed a scoring system to predict the risk of disease recurrence after stem cell transplantation in leukaemia patients

In 2023, semaglutide emerged as the top-selling drug in the USA, generating $13.8 billion in sales.

This variant results in reduced STAT6 protein levels, dampened IL-4 responses, and lower IgE and eosinophil counts in the blood.

Neoantigen DNA vaccines show safety and efficacy in reducing breast cancer recurrence, promising a personalised approach to immunotherapy in high-risk patients.

Kidney function decline in ATTR-CM predicts worse outcomes. Monitoring eGFR changes can guide interventions, improving clinical care for this progressive disease.